drugset / Trial / NCT00811200
Treatment Of Radiation Retinopathy Trial
RandomizedParallel-groupSingle-blindTreatment
Summary
The purpose of this study is to demonstrate a statistically significant improvement of visual acuity after treatment using either Lucentis® or Triamcinolone® compared to no treatment, in patients with radiation retinopathy.
Timeline
- Start
- 2009-09
- Primary completion
- 2012-01
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Ranibizumab | Monoclonal antibody | 0.5 mg | Intravitreal |
| Comparator | Triamcinolone Acetonide | Other / unclassified | 4 mg | Intravitreal |